(Q33951122)

30 July 2017

title

A quantitative study on the expression of synapsin II and N-ethylmaleimide-sensitive fusion protein in schizophrenic patients (English)

1 reference

30 July 2017

0 references

Imai C

1

1 reference

30 July 2017

Sugai T

2

1 reference

30 July 2017

Iritani S

3

1 reference

30 July 2017

Niizato K

4

1 reference

30 July 2017

Nakamura R

5

1 reference

30 July 2017

Makifuchi T

6

1 reference

30 July 2017

Kakita A

7

1 reference

30 July 2017

Takahashi H

8

1 reference

30 July 2017

Nawa H

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

30 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

30 July 2017

volume

305

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

185-188

1 reference

Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

The neuropathology of schizophrenia. A critical review of the data and their interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Catching up on schizophrenia: natural history and neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Expression monitoring by hybridization to high-density oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901844-4

7 January 2021

10.1016/S0304-3940(01)01844-4

Identifiers

DOI

1 reference

30 July 2017

1 reference